Inhibition of the expression of inducible nitric oxide synthase and cyclooxygenase-2 in macrophages by 7HQ derivatives: involvement of IkappaB-alpha stabilization

European Journal of Pharmacology
Y C HuangC M Teng

Abstract

Nitric oxide is an important biological mediator associated with multiple pathophysiological phenomena, such as platelet aggregation, vasodilation, septic shock, and autoimmune diseases. Prostaglandins, derived from cyclooxygenases, play prominent roles in homeostasis and inflammation. In this study, we characterized the effects of 7HQ derivatives (7-[(4-methylene-5-oxo-2-R-2-tetrahydrofuranyl) methoxy]-3,4-dihydrocarbostyril, where R is methyl, phenyl, p-fluorophenyl and p-phenylphenyl; 7HQ-1,-2,-3 and-4, respectively) in murine RAW 264.7 cells, a macrophage-like cell line. Lipopolysaccharide, the active component of endotoxin, significantly induced the expression of inducible nitric oxide synthase and cyclooxygenase-2, leading to the accumulation of nitrite and prostaglandin E(2), respectively. These actions of lipopolysaccharide were inhibited by 7HQ derivatives; additionally, the inhibition of the expression, rather than the activity, of inducible nitric oxide synthase correlated well with that of nitric oxide formation. Western blotting and electrophoretic mobility shift assay results demonstrated that the 7HQ derivatives could effectively inhibit IkappaB-alpha degradation and nuclear factor kappaB (NF-kappaB) translocatio...Continue Reading

References

Oct 1, 1977·Journal of Dental Research·L R BrownD A Johnston
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D SalveminiP Needleman
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C J LowensteinW J Murphy
Sep 23, 1994·Cell·H H Schmidt, U Walter
Jan 5, 1996·Biochimica Et Biophysica Acta·H R Herschman
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·L M LandinoL J Marnett
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Jan 1, 1997·Annual Review of Immunology·J MacMickingC Nathan
Aug 8, 1997·Journal of Toxicology and Environmental Health·P R Mayeux
Jul 1, 1997·Cellular and Molecular Life Sciences : CMLS·D Salvemini
Nov 18, 1997·Cell·I Stancovski, D Baltimore
Apr 30, 1998·The Keio Journal of Medicine·K Decker
Jun 5, 1998·Trends in Pharmacological Sciences·K R BleyJ A Smith
Jun 17, 1998·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·P P Wolkow
Jul 2, 1999·The American Journal of Medicine·L S Simon
Dec 10, 1999·The New England Journal of Medicine·C Robert, T S Kupper
Feb 19, 2000·Current Opinion in Immunology·E N HatadaC Scheidereit
Mar 4, 2000·Free Radical Biology & Medicine·R G Allen, M Tresini

❮ Previous
Next ❯

Citations

Aug 6, 2003·Life Sciences·Reiko KameiShinzo Oikawa
Dec 24, 2002·Current Opinion in Clinical Nutrition and Metabolic Care·Robert F Grimble

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.